Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Inhibition of hypoxia-inducible factor via upregulation of von Hippel-Lindau protein induces "angiogenic switch off" in a hepatoma mouse model.
Iwamoto H, Nakamura T, Koga H, Izaguirre-Carbonell J, Kamisuki S, Sugawara F, Abe M, Iwabata K, Ikezono Y, Sakaue T, Masuda A, Yano H, Ohta K, Nakano M, Shimose S, Shirono T, Torimura T. Iwamoto H, et al. Among authors: ikezono y. Mol Ther Oncolytics. 2015 Dec 2;2:15020. doi: 10.1038/mto.2015.20. eCollection 2015. Mol Ther Oncolytics. 2015. PMID: 27119112 Free PMC article.
Ex vivo expansion of circulating CD34(+) cells enhances the regenerative effect on rat liver cirrhosis.
Nakamura T, Koga H, Iwamoto H, Tsutsumi V, Imamura Y, Naitou M, Masuda A, Ikezono Y, Abe M, Wada F, Sakaue T, Ueno T, Ii M, Alev C, Kawamoto A, Asahara T, Torimura T. Nakamura T, et al. Among authors: ikezono y. Mol Ther Methods Clin Dev. 2016 Apr 27;3:16025. doi: 10.1038/mtm.2016.25. eCollection 2016. Mol Ther Methods Clin Dev. 2016. PMID: 27162932 Free PMC article.
Glycosylation of ascites-derived exosomal CD133: a potential prognostic biomarker in patients with advanced pancreatic cancer.
Sakaue T, Koga H, Iwamoto H, Nakamura T, Ikezono Y, Abe M, Wada F, Masuda A, Tanaka T, Fukahori M, Ushijima T, Mihara Y, Naitou Y, Okabe Y, Kakuma T, Ohta K, Nakamura KI, Torimura T. Sakaue T, et al. Among authors: ikezono y. Med Mol Morphol. 2019 Dec;52(4):198-208. doi: 10.1007/s00795-019-00218-5. Epub 2019 Feb 25. Med Mol Morphol. 2019. PMID: 30805710 Clinical Trial.
CD34(+) cell therapy is safe and effective in slowing the decline of hepatic reserve function in patients with decompensated liver cirrhosis.
Nakamura T, Torimura T, Iwamoto H, Kurogi J, Inoue H, Hori Y, Sumie S, Fukushima N, Sakata M, Koga H, Abe M, Ikezono Y, Hashimoto O, Ueno T, Oho K, Okamura T, Okuda S, Kawamoto A, Ii M, Asahara T, Sata M. Nakamura T, et al. Among authors: ikezono y. J Gastroenterol Hepatol. 2014 Oct;29(10):1830-8. doi: 10.1111/jgh.12622. J Gastroenterol Hepatol. 2014. PMID: 24731186
11 results